Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis ‐ results from the <scp>CHIKARA</scp> study

Abstract

The prevalence of sarcopenia was 28% in patients with RA whose disease activity was mild. Low BMI, high fat mass and high MMP3 were independently associated with sarcopenia. MMP3 might be a useful marker for sarcopenia in patients with RA.